Home

WASHINGTON, DC (January 25, 2023) – LUNGevity Foundation is pleased to partner with Rising Tide Foundation, a global philanthropic organization based in Switzerland, to issue a Request for Application (RFA) to study how shared mechanisms of resistance can be targeted in oncogene-driven lung cancers.

WASHINGTON, DC (January 25, 2023) – LUNGevity Foundation is honored to announce its second research partnership with the EGFR Resisters in issuing a Request for Application (RFA) for high-impact research focused on EGFR-positive lung cancer.

WASHINGTON, DC (January 25, 2023) – LUNGevity Foundation is partnering with the American Society for Radiation Oncology (ASTRO), the world’s largest radiation oncology society, to support radiation oncology research — an important area of study for the early detection and treatment of lung cancer.

WASHINGTON, DC (January 25, 2023) – Continuing a long-term commitment to improving outcomes for lung cancer patients by supporting the next generation of lung cancer researchers, LUNGevity Foundation, the nation’s leading lung cancer-focused nonprofit, has issued five Requests for Application (RFAs).

WASHINGTON, DC (January 23, 2023) – LUNGevity Foundation, the nation’s leading lung cancer-focused nonprofit organization, welcomes Michelle Futrell, MSN, MBA, RN, as Director of Lung Cancer Screening Programs and Initiatives.